Table 1.
Baseline patient characteristics.
| Baseline characteristics | All patients | CD25+ | CD25− | p value |
|---|---|---|---|---|
| N (%) | 58 (100) | 20 (34.5) | 38 (65.5) | |
| Age | 73 | 75 | 71 | p=.065 |
| Mean range | (56–87) | (62–87) | (56–82) | |
| Sex, n (%) | ||||
| Male | 33 (57) | 15 (75%) | 18 (47.3) | p=.054 |
| Female | 25 (43) | 5 (25%) | 20 (52.7) | |
| WBC (×1000/µL) | 5.9 | 19 | 5 | p=.088 |
| Median (IQR) range | (0.6–122.0) | (0.8–122) | (1.1–42) | |
| LDH (IU/L) | 284 | 360.5 | 270 | p=.040 |
| Median (IQR) range | (79–1901) | (136–1384) | (79–1901) | |
| Bone marrow blast percentage – mean (SD) | 50.0 (26.5) | 54.2 (31.6) | 47.7 (23.6) | p=.386 |
| Range | (4–74) | (4–95) | (6–85) | |
| Cytogenetics, n (%) | ||||
| Favorable | 4 (7) | 1(5) | 3(8) | |
| Intermediate | 33 (57%) | 15 (75) | 18 (47) | p=.047 |
| Unfavorable | 21 (36.2) | 4 (20) | 17 (44) | |
| Transplanta status, n (%) | ||||
| Yes | 17 (29.3) | 5 (25) | 12 (31.6) | p=.764 |
| No | 41 (70.7) | 15(75) | 26 (68.4) |
a
All transplants were allogeneic.
n: number; WBC: white blood cell count; IQR: interquartile range; SD: standard deviation.